Literature DB >> 2851352

Evaluation of opioid-induced antinociceptive effects in anaesthetized and conscious animals.

S J Clark1, R L Follenfant, T W Smith.   

Abstract

1. The activity profiles of opioid agonists and non-steroidal analgesic agents have been compared against different nociceptive stimuli in the mouse and rat. 2. Opioid agonists, but not non-steroidal analgesic agents, inhibited reflex depressor responses evoked by visceral distension in anaesthetized rats. The ranked order of potency of opioids in the visceral distension reflex was identical to that observed in the mouse writhing assay. 3. Opioid-induced inhibition of reflex depressor responses and writhing was observed with ligands acting on mu- and kappa-, but not delta-receptors. Antinociceptive activity of opioids in the rat cold water tail-flick assay was restricted to mu-receptor agonists. 4. Morphine- and ethylketocyclazocine (EKC)-induced inhibition of the visceral distension reflex was blocked by naloxone, but not by the quaternary opioid antagonist N-methylnalorphine. 5. Direct cardiovascular effects were observed with ligands for the mu- and kappa-receptor. Blood pressure changes induced by morphine and Tyr.D-Ala.Gly.MePhe.Gly-ol (DAGOL), but not EKC, were blocked by N-methylnalorphine. Pretreatment with 16-methylcyprenorphine (M8008) antagonized morphine-, DAGOL- and EKC-induced cardiovascular effects, but not those of dynorphin-(1-13) or U50488. 6. It is concluded that reflex circulatory responses evoked by visceral distension in anaesthetized rats are a valid index for the evaluation of opioid-induced antinociception. A simultaneous assessment of cardiovascular effects of opioids was achieved.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851352      PMCID: PMC1854116          DOI: 10.1111/j.1476-5381.1988.tb16574.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

2.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

3.  ICI 174864: a highly selective antagonist for the opioid delta-receptor.

Authors:  R Cotton; M G Giles; L Miller; J S Shaw; D Timms
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

4.  Studies in suppression of nocifensive reflexes measured with tail flick electromyograms and using intrathecal drugs in barbiturate anesthetized rats.

Authors:  J M Peets; B Pomeranz
Journal:  Brain Res       Date:  1987-07-28       Impact factor: 3.252

5.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

6.  Peripheral antinociceptive effects of N-methyl morphine.

Authors:  T W Smith; P Buchan; D N Parsons; S Wilkinson
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

7.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

8.  Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs.

Authors:  M B Given; G E Sander; T D Giles
Journal:  Life Sci       Date:  1986-04-07       Impact factor: 5.037

9.  Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.

Authors:  S Laurent; H Schmitt
Journal:  Eur J Pharmacol       Date:  1983-12-09       Impact factor: 4.432

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  4 in total

1.  Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

2.  Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Antinociception of petroleum ether fraction derived from crude methanol extract of Melastoma malabathricum leaves and its possible mechanisms of action in animal models.

Authors:  Z A Zakaria; E S Jaios; M H Omar; S Abd Rahman; S S A Hamid; S M Ching; L K Teh; M Z Salleh; S Deny; M Taher
Journal:  BMC Complement Altern Med       Date:  2016-11-29       Impact factor: 3.659

4.  Mechanistic assessment of the analgesic, anti-inflammatory and antipyretic actions of Dalbergia saxatilis in animal models.

Authors:  Omoniyi K Yemitan; Olufunmilayo O Adeyemi
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.